跳至主要内容
临床试验/NCT07396064
NCT07396064尚未招募不适用

Bridging the Gap: Enhancing Cancer Care for Underserved Populations With the Veris Health Cancer Care Platform

VERIS HEALTH INC1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年2月16日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Usability of the Veris Health Cancer Care Platform

研究概览

简要总结

The proposed study aims to optimize and validate the Veris Cancer Care Platform for the needs of medically underserved cancer patients receiving outpatient cancer therapy. The Veris Health platform is a remote patient monitoring and communication system designed to bridge the gap between clinical visits and provide oncology care teams with objective data during high-risk periods.

This study will specifically focus on optimizing the Veris Health platform for patients with language barriers, limited access to technology, and socioeconomic disparities. By incorporating user-centered design and working closely with community health centers, the research team will ensure that the platform is culturally and linguistically appropriate, easy to use, and accessible for all patients.

The study will use a mixed-methods approach to validate the effectiveness of the optimized platform, including quantitative data analysis and qualitative interviews with patients and healthcare providers. The goal is to demonstrate the potential for the Veris Health platform to improve outcomes for vulnerable populations by reducing hospitalizations, emergency department visits, and the economic burden of cancer care.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults > 18 years old
  • Diagnosis of cancer
  • ECOG Performance Status of 0-2
  • Undergoing or initiating systemic anticancer therapy
  • Able to utilize and interact with a mobile application and in-home devices for physiological monitoring. Have at least one of the following barriers to healthcare access: Spanish as primary language, uninsured, insured with Medicaid, dual eligible for Medicare and Medicaid

排除标准

  • 未提供

研究组 & 干预措施

Main Phase group

All participating subject utilizing the Veris Health app will complete all study health measurements with a 24 week period on the Veris Health app as well as participate in interviews and focus groups.

干预措施: Veris Health Inc. Application (Other)

结局指标

主要结局

Usability of the Veris Health Cancer Care Platform

时间窗: 5 Months

Usability of the Veris Health Cancer Care platform as assessed by the Software Usability Measurement Inventory (SUMI) among patients, caretakers, and healthcare teams. Measure: SUMI total and domain scores Time Frame: During study participation

Product Design Usability and Acceptability

时间窗: 5 Months

Ease of use, accessibility, and acceptability of the Veris Health Cancer Care platform based on A/B testing of product design features. Measure: Comparative usability metrics (e.g., task completion success, user preference) Time Frame: During study participation

User Needs and Preferences

时间窗: 5 Months

User-identified needs, preferences, and barriers to use of the Veris Health Cancer Care platform. Measure: Qualitative themes derived from user interviews and focus groups Time Frame: During study participation

次要结局

  • Health-Related Quality of Life (HRQL)(5 Months)
  • Symptom Burden of Cancer Treatment Side Effects(5 Months)
  • Cancer Treatment Adherence and Duration(5 months)

研究者

发起方
VERIS HEALTH INC
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验